Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Nayara Franco"'
Autor:
Andrea Baldasso-Zanon, Andrew Oliveira Silva, Nayara Franco, Rafael Picon, Guido Lenz, Patrícia Luciana da Costa Lopez, Eduardo Filippi-Chiela
Colorectal cancer (CRC) is the third most common and deadliest cancers globally. The primary chemotherapy used for treating CRC is a co-treatment of 5-fluoruracil (5FU) and Oxaliplatin (OXA). In this study, we investigated the cellular mechanisms tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0c2cec588e3650c47531c044e383d0e
https://doi.org/10.21203/rs.3.rs-2975359/v1
https://doi.org/10.21203/rs.3.rs-2975359/v1
Autor:
Andréa Baldasso Zanon, Guido Lenz, Nayara Franco, Patrícia Luciana da Costa Lopez, Eduardo C. Filippi-Chiela
Publikováno v:
Clinical Cancer Research. 24:B36-B36
Colorectal cancer (CRC) is among the most common and aggressive cancers worldwide. Primary therapy to CRC includes 5-fluoruracil (5-FU) and oxaliplatin (Oxa). Here, we aim to investigate the cellular mechanisms that mediate the response of CRC to the